SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-148114
Filing Date
2024-05-28
Accepted
2024-05-28 16:27:32
Documents
13
Period of Report
2024-05-24
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d794252d8k.htm   iXBRL 8-K 28159
  Complete submission text file 0001193125-24-148114.txt   153545

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA howl-20240524.xsd EX-101.SCH 2848
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE howl-20240524_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE howl-20240524_pre.xml EX-101.PRE 11706
16 EXTRACTED XBRL INSTANCE DOCUMENT d794252d8k_htm.xml XML 3772
Mailing Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472 617-952-0555
Werewolf Therapeutics, Inc. (Filer) CIK: 0001785530 (see all company filings)

IRS No.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40366 | Film No.: 24992281
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)